Kobayashi Pharmaceutical Co., Ltd.
Important Dates
Kobayashi Pharmaceutical Co., Ltd.'s next confirmed earnings release is scheduled for November 10, 2026.
| Earnings Date | 11/10/2026 |
Share Statistics
As of June 30, 2026, Kobayashi Pharmaceutical Co., Ltd. has 74.34M shares outstanding.
| Shares Outstanding | 74.34M |
Financial Position
As of June 30, 2026, Kobayashi Pharmaceutical Co., Ltd. maintains a current ratio of 3.28, meaning it holds 3.3x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 3.28 |
| Quick Ratio | 1.51 |
| Debt / Equity | 0.34 |
Financial Efficiency
These figures cover the twelve months ended June 30, 2026.
| Employee Count | 3,702.00 |
Stock Price Statistics
As of the close on September 24, 2026, Kobayashi Pharmaceutical Co., Ltd.'s stock has gained approximately 5.45% over the past 52 weeks.
| 52-Week Price Change | 5.45% |
Balance Sheet
USDAs of June 30, 2026, Kobayashi Pharmaceutical Co., Ltd. holds 352.65M in cash and equivalents against 4.45M in total debt, resulting in a net debt position of -289.29M. Total book value stands at 1.29B, with working capital of 533.67M providing operational flexibility.
| Cash & Cash Equivalents | 352.65M |
| Total Debt | 4.45M |
| Net Debt | -289.29M |
| Equity (Book Value) | 1.29B |
| Book Value Per Share | 17.35 |
| Working Capital | 533.67M |
Stock Splits
Kobayashi Pharmaceutical Co., Ltd.'s most recent stock split took place on June 28, 2016 with a 1:2 split ratio.
| Last Split Date | 6/28/2016 |
| Split Ratio | 1:2 |